[A comparative study of fludarabine-based versus CHOP-like regimens in untreated primary indolent lymphoma]
Zhonghua Xue Ye Xue Za Zhi
.
2013 Oct;34(10):900-3.
doi: 10.3760/cma.j.issn.0253-2727.2013.10.017.
[Article in Chinese]
Authors
Xiao-xiao Xu
1
,
Bei Yan
,
Zhen-xing Wang
,
Yong Yu
,
Hong-liang Yang
,
Dan-dan Zhao
,
Ya-fei Wang
,
Xiao-xiong Wu
,
Yi-zhuo Zhang
Affiliation
1
Department of Hematology, Tianjin Medical University Cancer Institute and Hospital, Tianjin Key Laboratory of Cancer Prevention and Therapy, Tianjin 300060, China.
PMID:
24171969
DOI:
10.3760/cma.j.issn.0253-2727.2013.10.017
No abstract available
Publication types
Comparative Study
MeSH terms
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
Humans
Lymphoma, Non-Hodgkin / drug therapy*
Vidarabine / analogs & derivatives*
Vidarabine / therapeutic use
Substances
Vidarabine
fludarabine